These stocks have an unusual volume in today's session
By Mill Chart
Last update: Jul 10, 2024
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| VRPX | 85.28% | 107.96M shares of VIRPAX PHARMACEUTICALS INC (NASDAQ:VRPX) exchanged hands today. The share price of NASDAQ:VRPX increased by 85.28% today, reflecting positive market movement. In comparison to the average daily volume of the last 50 days, the current volume is 3.0K% above. This suggests a notable change in trading activity. A press release (Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™) was released earlier today. |
| JNVR | 10.13% | With 717.15K shares traded so far, JANOVER INC (NASDAQ:JNVR) is experiencing an unusual level of activity today. The market is favoring NASDAQ:JNVR today, as its share price records a notable increase of 10.13%. This is 98.65% above the average daily volume of the last 50 days. A press release (Janover’s New Insurtech Platform Launches D&O Liability Insurance for Publicly Traded Companies) was released yesterday. |
| SNGX | 4.85% | 14.39M shares of SOLIGENIX INC (NASDAQ:SNGX) have been traded so far today. NASDAQ:SNGX is experiencing an advancement of 4.85% in its share price today. Compared to the average daily volume of the past 50 days, the current volume is 393.0% above, suggesting an unusual level of trading activity. |
| VVPR | 56.92% | 36.4M shares of VIVOPOWER INTERNATIONAL PLC (NASDAQ:VVPR) have been traded so far today. The market is favoring NASDAQ:VVPR today, as its share price records a notable increase of 56.92%. Today's trading volume is 2.0K% above the average 50-day volume, indicating a significant deviation from the norm. |
| ATNF | -15.46% | So far 1.06M shares of 180 LIFE SCIENCES CORP (NASDAQ:ATNF) have traded in today's session. NASDAQ:ATNF is experiencing a downward trend, with a decline of 15.46%. The average volume over the last 50 days is 758.31K, making today's volume 39.24% above the average. This signifies a notable change in market participation. |
| MAXN | -12.94% | So far 168.35M shares of MAXEON SOLAR TECHNOLOGIE (NASDAQ:MAXN) have traded in today's session. Shares are falling by 12.94%. With an average daily volume of 37.53M over the past 50 days, today's volume is 349.0% above the average, indicating a potential shift in market sentiment. A press release (ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Maxeon Solar Technologies, Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MAXN) was released earlier today. |
| LGMK | -9.84% | So far 174.89K shares of LOGICMARK INC (NASDAQ:LGMK) have traded in today's session. NASDAQ:LGMK is showing a decline of 9.84% in today's trading. Today's trading volume is 31.27% above the average 50-day volume, indicating a significant deviation from the norm. |
| HLVX | -2.37% | HILLEVAX INC's (NASDAQ:HLVX) traded a high volume of 1.53M shares. NASDAQ:HLVX is declining 2.37% today. The average volume over the last 50 days is 845.24K, making today's volume 80.49% above the average. This signifies a notable change in market participation. |
| MORF | 0.13% | Today, MORPHIC HOLDING INC (NASDAQ:MORF) stands out with a high volume of 4.9M shares. NASDAQ:MORF is experiencing an advancement of 0.13% in its share price today. The average daily volume over the past 50 days is 1.82M. Hence, the current volume is 169.0% above the average volume, indicating a deviation from the usual trading pattern. Yesterday the company had a press release: Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage. |
| QURE | 49.77% | So far 40.6M shares of UNIQURE NV (NASDAQ:QURE) have traded in today's session. Leading to a price increase of 49.77%. The average volume over the last 50 days is 1.58M, making today's volume 2.0K% above the average. This signifies a notable change in market participation. Yesterday the company had a press release: uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
